Esflurbiprofen

CHEMBL435298 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
244.3 g/mol
LogP
4.2
Phase
4

This anti-inflammatory medication reduces pain and swelling by blocking enzymes called COX-1 and COX-2 that produce inflammatory chemicals. It is the S-enantiomer of flurbiprofen and may be used for pain relief.

น้ำหนักโมเลกุล

244.2600 g/mol

LogP

4.20

TPSA

37.30 Ų

Lipinski RO5

ผ่าน

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1

InChI

InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m0/s1

Molecular Formula

C15H13FO2

HBD / HBA

1 / 3

พันธะที่หมุนได้

3

อะตอมหนัก

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

This anti-inflammatory medication reduces pain and swelling by blocking enzymes called COX-1 and COX-2 that produce inflammatory chemicals. It is the S-enantiomer of flurbiprofen and may be used for pain relief.

Yes, Esflurbiprofen is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL435298. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 72099. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.